GlassScriptPhysician profile
Balraj Singh
NPI 1508097452
$2,288.67
in general payments reported to CMS, 2019-2025
19 companies · $55.10 in 2025
The $55.10 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,229 · 2021: $314 · 2022: $150 · 2023: $358 · 2024: $183 · 2025: $55.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $595.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,316.71 | 2019-2023 | Supera |
| Boston Scientific Corporation | $208.36 | 2021-2023 | Lux-Dx Insertable Cardiac Monitor, Watchman Access System, Watchman Flx |
| W. L. Gore & Associates, INC. | $130.86 | 2023 | Gore Septal Occluder |
| Medtronic, INC. | $123.90 | 2021 | |
| Shockwave Medical, INC | $101.20 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $99.30 | 2021 | |
| Kestra Medical Technology Services, INC. | $76.67 | 2024-2025 | Assure Wcd |
| Amgen INC. | $57.53 | 2024 | Repatha |
| Kiniksa Pharmaceuticals International, Plc | $31.77 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $18.93 | 2024 | |
| Sirtex Medical INC | $17.98 | 2022 | |
| Novo Nordisk INC | $16.70 | 2024 | Ozempic |
| E.R. Squibb & Sons, L.L.C. | $16.62 | 2019 | |
| Irhythm Technologies, INC. | $15.65 | 2024 | Zio Xt Patch |
| Novartis Pharmaceuticals Corporation | $15.51 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $14.45 | 2019 | |
| Portola Pharmaceuticals, LLC | $12.08 | 2019 | |
| Sensible Medical Innovations INC | $9.21 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $5.24 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Balraj Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.